English to Romanian Medical Medical: Pharmaceuticals

The benefits for Member states would be a lower negotiated price and the respect of the legal delay for orphan drug availability; for pharmaceutical companies, it would mean earlier return on investment and more visibility and predictability of returns; for patients - and that’s the whole point - earlier availability of orphan medicinal products.